Lymphoma TopicsShow More
Hear from a doctor on the front lines of research into CAR T-cell therapy, a promising new immunotherapy for treatment-resistant non-Hodgkin’s lymphoma.
Dr. Gwen Nichols, chief medical officer of the Leukemia & Lymphoma Society discusses major developments and what the future holds for non-Hodgkin's lymphoma treatment.
There are four phases of clinical trials. Learn about each phrase — and your potential to take part — in this article.